Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
"Despite rising demand, India's obesity market remains largely under-penetrated, offering significant headroom for both innovators and generic entrants," Sheetal Sapale, vice-president (commercial) at Pharmarack said.Entry of low-priced generics from March after semaglutide (key ingredient in the blockbuster weight-loss jab) loses patent protection, along with potential price cuts by innovators, is expected to further accelerate growth in the fastest growing therapy
This process generally unfolds over time as your body adapts to the lower calorie intake
They depend on diet, health, and other digestive issues
How PlexusDx Supports a More Personalized Approach PlexusDx's biomarker-informed approach recognizes that baseline lab work and genetic predisposition screening help providers optimize your GLP-1 therapy from day one
![How Stonehenge Health® Saved $1M in 1 Year by Switching to ShipBob Plus [Case Study]](https://www.shipbob.com/wp-content/uploads/2026/03/e01edfb85c6b94277af4e3d87484d747-e1773694612896.webp)
US$ 27.23
US$ 22.35
US$ 26.39
